A Comprehensive Study on Counterfeit Medicine and its prevention in India through its Regulatory Approach

  • Suryaprakash Singh Chandigarh College of Pharmacy
  • Priyanka Gupta

Abstract

A counterfeit medication is one which is intentionally and false mislabeled with relevance identity or source. Counterfeiting applies to both brand and generic products which incorporate items with wrongs ingredients, without active ingredients, with inadequate active ingredients. Worldwide, each nation is that the survivor of substandard or spurious drugs, which end in life threatening issues, loss of consumer and manufacturer and loss in trust on health system. Internationally, the trade in counterfeit drug is of the quickest developing grey economies – after narcotics, terrorism, and arm trade.


In term of revenues, India Is world’s leading in generic companies. India has the notoriety of being a significant producer of the world's counterfeit drugs. Counterfeit drugs structure 10% of the counterfeit drugs in line with the world Health Organization (WHO).  As Per BASCAP-"Drug industry is that the premier falsified industry in India".


The point of this enumerative review was to clarify the effect of poor-quality drugs with their outcomes on public health and also the preventive measures taken by the Indian drug administrative framework by CDSCO. India should adopt the technologies present in other countries to combat counterfeit medicine.

Keywords: Counterfeit, CDSCO, WHO, BASCAP

Downloads

Download data is not yet available.

References

1. Verma, S., R. Kumar, and P. Philip. The business of counterfeit drugs in India: A critical evaluation. International Journal of Management and International Business Studies, [Internet]. 2014 Nov[cited 2022 Jan 15]; 4(2) : 141-148 Available from:
https://www.researchgate.net/publication/340581356_The_Business_of_Counterfeit_Drugs_in_India_A_Critical_Evaluation
2. Ozawa, S., et al. Access to medicines through health systems in low-and middle-income countries. 2019, Oxford University Press [Internet]. 2019 Dec[cited 2022 Jan 19]; iii1-iii3 Available from:
https://academic.oup.com/heapol/article/34/Supplement_3/iii1/5670624
3. Yadav, S. and G. Rawal. Counterfeit drugs: problem of developing and developed countries. Int J Pharmceut Chem Anal [Internet]. 2015 Mar[cited 2022 Jan 25]; 2(1): 6-50 Available from:
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Yadav%2C+S.+and+G.+Rawal%2C+Counterfeit+drugs%3A+problem+of+developing+and+developed+countries.+Int+J+Pharmceut+Chem+Anal%2C&btnG=#
4. Kumar, P. A Study on Spurious and Not of Standard Quality Drugs in the State of Andhra Pradesh. African Journal of Pharmacy and Pharmacology [Internet]. 2018 Mar[cited 2022 Feb15]; 12(10) : 30-135 Available from: https://academicjournals.org/journal/AJPP/article-abstract/4EC3AD856268
5. Khan, A. and R. Khar. Current scenario of spurious and substandard medicines in India: a systematic review. Indian journal of pharmaceutical sciences [Internet]. 2015 Mar[cited 2022 Feb 08]; 77(1):2.Available from: https://www.researchgate.net/publication/273464064_Current_Scenario_of_Spurious_and Substandard_Medicines_in_India_A_Systematic_Review
6. Swaminath, G. Faking it-I The menace of counterfeit drugs. Indian journal of psychiatry [Internet]. 2008 Oct[cited 2022 Feb 5]; 50(4): 238. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755136/
7. Buowari, O., Fake and counterfeit drug: a review. Afrimedic Journal [Internet]. 2013 Mar[cited 2022 Mar 15];3(2):1-4.Available from:
https://www.ajol.info/index.php/afrij/article/view/86573
8. Gupta, P., K. Singhal, and A. Pandey. Counterfeit (fake) drugs & new technologies to identify it in India. International Journal of Pharmaceutical Sciences and Research [Internet]. 2012 Nov[cited 2022 Feb 01]; 3(11): 4057. Available from:
https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.278.7488&rep=rep1&type=pdf
9. Wertheimer, A.I., N.M. Chaney, and T. Santella. Counterfeit pharmaceuticals: current status and future projections. Journal of the american pharmacists association [Internet]. 2003 Nov[cited 2022 Feb 21]; 43(6): 710-718. Available from:
https://www.sciencedirect.com/science/article/abs/pii/S1544319115318732
10. O'Hagan, A. and A. Garlington. Counterfeit drugs and the online pharmaceutical trade, a threat to public safety. Forensic Research & Criminology International Journal [Internet]. 2018 May [cited 2022 March 22] 6(3): 151-158. Available from:
http://irep.ntu.ac.uk/id/eprint/33978/
11. Shah, N.A., et al. Counterfeit drugs in India: significance and impact on pharmacovigilance [Internet]. 2015 Aug [cited 2022 Jan11]; 3(9):2156-2160. Available from:
http://14.139.121.113:8083/jspui/handle/123456789/247
12. Kumar, D.P., et al. Current Trends in Regulatory Authority Actions against Misbranded and Adulterated Drugs. International Journal of Advance Research, Ideas and Innovation in Technology [Internet]. 2017 Jun[cited 2022 Feb 28]; 3(3):1513-1521. Available from:
https://www.semanticscholar.org/paper/Current-Trends-in-Regulatory-Authority-Actions-and-Kumar-Umasankar/0b0aa964840f4fe883d39656ebd20273316f2624
13. Bansal, D., et al. Anti-counterfeit technologies: a pharmaceutical industry perspective. Scientia pharmaceutica [Internet]. 2012 Oct [cited 2022 Mar 09]; 81(1):1-14. Available from:
https://www.mdpi.com/2218-0532/81/1/1
14. Dass, R. and B. Gajjar. Anti-counterfeit technologies for spurious drugs in India. International Journal of User-Driven Healthcare (IJUDH) [Internet]. 2011 Oct[cited 2022 March 01]; 1(4):42-52. Available from:
https://www.igi-global.com/article/international-journal-user-driven.../61321
Statistics
243 Views | 322 Downloads
How to Cite
Singh, S., and P. Gupta. “A Comprehensive Study on Counterfeit Medicine and Its Prevention in India through Its Regulatory Approach”. International Journal of Drug Regulatory Affairs, Vol. 10, no. 2, June 2022, pp. 9-13, doi:10.22270/ijdra.v10i2.515.